Company News in the Life Science Industry

»

Reset 

ObsEva and Yuyuan BioScience Technology Announce Sublicense Agreement to Develop and Commercialize Nolasiban in the People's Republic of China

Read more ››
By: GlobenewsWire - 13 Jan 2020
Related companies:  ObsEva SA

Hansa Biopharma Provides Business Update Ahead of the JP Morgan Global Healthcare Conference

LUND, Sweden, Jan. 13, 2020 /PRNewswire/ -- Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced a business update for the fourth quarter 2019 and preliminary, unaudited key financials for its financial year 2019.

Read more ››
By: PR Newswire Association LLC. - 13 Jan 2020
Related companies:  Hansa Biopharma AB

Tyvyt (Sintilimab Injection) Combined with ALIMTA (Pemetrexed) and Platinum Met Predefined Primary Endpoint in Phase 3 ORIENT-11 Study as First-Line Therapy in Nonsquamous NSCLC

SUZHOU, China, Jan. 13, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, today jointly announced... Read more ››

By: PR Newswire Association LLC. - 13 Jan 2020
Related companies:  Eli Lilly and Company

Mundipharma Enters Partnership With Samsung Bioepis to Expand Biosimilars Into Hong Kong and Taiwan

SINGAPORE, Jan. 12, 2020 /PRNewswire/ -- Mundipharma today announced a partnership with Samsung Bioepis to commercialize Samsung Bioepis' first-wave biosimilar candidates in Taiwan and Hong Kong.

Read more ››
By: PR Newswire Association LLC. - 13 Jan 2020
Related companies:  Mundipharma Research GmbH & Co. KG

Accelerate Diagnostics Announces Preliminary Fourth Quarter and Full-Year 2019 Financial Results

TUCSON, Ariz., Jan. 13, 2020 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX), today announced preliminary financial results for the quarter and year ending December 31, 2019. Highlights for the fourth quarter and full-year 2019 are presented below.

Read more ››
By: PR Newswire Association LLC. - 13 Jan 2020
Related companies:  Accelerate Diagnostics, Inc.

Adverum Biotechnologies Reports Continued Momentum with OPTIC Trial for ADVM-022 Intravitreal Gene Therapy in Wet AMD and Provides 2020 Outlook

Read more ››
By: GlobenewsWire - 13 Jan 2020
Related companies:  Adverum Biotechnologies, Inc.

GW Pharmaceuticals Pre-Announces Preliminary Unaudited Fourth Quarter and Full-Year 2019 Net Product Sales

Read more ››
By: GlobenewsWire - 13 Jan 2020
Related companies:  GW Pharmaceuticals plc

Ascendis Pharma A/S Provides Pipeline Update and Reviews Progress Towards Vision 3x3 at 38th Annual J.P. Morgan Healthcare Conference

Read more ››
By: GlobenewsWire - 13 Jan 2020
Related companies:  Ascendis Pharma A/S

Oyster Point Pharma’s OC-01 Nasal Spray Meets Primary Endpoint in Phase 2 Mystic Trial in Subjects With Dry Eye Disease

Read more ››
By: GlobenewsWire - 13 Jan 2020
Related companies:  Oyster Point Pharma, Inc.

Neurocrine Biosciences Provides Preliminary Fourth Quarter and Full-Year 2019 Net Product Sales Results and 2020 Program Milestones

SAN DIEGO, Jan. 12, 2020 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today provided an update on its business performance, including preliminary net product sales results for 2019, and key commercial and clinical development milestones for 2020. Kevin Gorman, Chief Executive Officer... Read more ››

By: PR Newswire Association LLC. - 13 Jan 2020
Related companies:  Neurocrine Biosciences, Inc.

Exact Sciences Announces Preliminary Fourth Quarter 2019 Results

MADISON, Wis., Jan. 12, 2020 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company expects to report revenue between $294 million and $296 million for the fourth quarter ended Dec. 31, 2019.

Read more ››
By: PR Newswire Association LLC. - 13 Jan 2020
Related companies:  Exact Sciences Corp.

Agios Announces “Agios 2025” Strategic Vision and Highlights 2020 Milestones

Read more ››
By: GlobenewsWire - 12 Jan 2020
Related companies:  Agios Pharmaceuticals, Inc.

BioCryst to Provide Berotralstat and BCX9930 Program Updates at 38th Annual J.P. Morgan Healthcare Conference

Read more ››
By: GlobenewsWire - 12 Jan 2020
Related companies:  BioCryst Pharmaceuticals, Inc.

Iovance Biotherapeutics and Cellectis Enter into a Research Collaboration and Exclusive Worldwide License Agreement

Read more ››
By: GlobenewsWire - 12 Jan 2020
Related companies:  Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics Obtains License to Develop and Commercialize a Novel IL-2 Analog

Read more ››
By: GlobenewsWire - 12 Jan 2020
Related companies:  Iovance Biotherapeutics, Inc.

Veloxis Pharmaceuticals:  Reminder of Approaching Deadline for the Acceptance of the Public Tender Offer by Asahi Kasei Pharma Denmark

Read more ››
By: GlobenewsWire - 12 Jan 2020
Related companies:  Veloxis Pharmaceuticals A/S

Invitae preliminary 2019 financial results demonstrate strong momentum with nearly 60% growth in test volume and more than 45% growth in revenue year-over-year

SAN FRANCISCO, Jan. 12, 2020 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, announced... Read more ››

By: PR Newswire Association LLC. - 12 Jan 2020
Related companies:  Invitae Corporation

Luminex Corporation Announces 2019 Highlights and 2020 Guidance; Company to Present at 38th Annual J.P. Morgan Healthcare Conference

AUSTIN, Texas, Jan. 12, 2020 /PRNewswire/ -- Luminex Corporation (Nasdaq: LMNX) today announced 2019 highlights and 2020 guidance.

Read more ››
By: PR Newswire Association LLC. - 12 Jan 2020
Related companies:  Luminex Corporation

Teladoc Health to Acquire InTouch Health

Read more ››
By: GlobenewsWire - 12 Jan 2020
Related companies:  Teladoc, Inc.

Atara Biotherapeutics to Present 2020 Key Milestones and Progress in Bringing Off-The-Shelf, Allogeneic T-Cell Immunotherapies to Patients in Need at the 38th Annual J.P. Morgan Healthcare Conference

Read more ››
By: GlobenewsWire - 12 Jan 2020
Related companies:  Atara Biotherapeutics, Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23 24  25 »

Explore our database of over 50,000 companies